| 1 | our sites pituitaryorgacromegalyorgpituitarybookscom home | | | | | | | 1 | 0.13% |
| 2 | progestin prempro was associated | | | | | | | 1 | 0.13% |
| 3 | longterm followup over 13 | | | | | | | 1 | 0.13% |
| 4 | followup over 13 years | | | | | | | 1 | 0.13% |
| 5 | over 13 years the | | | | | | | 1 | 0.13% |
| 6 | 13 years the combination | | | | | | | 1 | 0.13% |
| 7 | years the combination of | | | | | | | 1 | 0.13% |
| 8 | the combination of estrogen | | | | | | | 1 | 0.13% |
| 9 | combination of estrogen and | | | | | | | 1 | 0.13% |
| 10 | prempro was associated with | | | | | | | 1 | 0.13% |
| 11 | protect against it according | | | | | | | 1 | 0.13% |
| 12 | was associated with a | | | | | | | 1 | 0.13% |
| 13 | associated with a 28 | | | | | | | 1 | 0.13% |
| 14 | with a 28 increased | | | | | | | 1 | 0.13% |
| 15 | a 28 increased risk | | | | | | | 1 | 0.13% |
| 16 | 28 increased risk of | | | | | | | 1 | 0.13% |
| 17 | increased risk of invasive | | | | | | | 1 | 0.13% |
| 18 | breast cancer comparable with | | | | | | | 1 | 0.13% |
| 19 | against it according to | | | | | | | 1 | 0.13% |
| 20 | may protect against it | | | | | | | 1 | 0.13% |
| 21 | comparable with the 24 | | | | | | | 1 | 0.13% |
| 22 | womens health initiative whi | | | | | | | 1 | 0.13% |
| 23 | breast cancer risk seen | | | | | | | 1 | 0.13% |
| 24 | cancer risk seen with | | | | | | | 1 | 0.13% |
| 25 | risk seen with combination | | | | | | | 1 | 0.13% |
| 26 | hormone therapy in the | | | | | | | 1 | 0.13% |
| 27 | therapy in the womens | | | | | | | 1 | 0.13% |
| 28 | in the womens health | | | | | | | 1 | 0.13% |
| 29 | the womens health initiative | | | | | | | 1 | 0.13% |
| 30 | health initiative whi trial | | | | | | | 1 | 0.13% |
| 31 | alone may protect against | | | | | | | 1 | 0.13% |
| 32 | initiative whi trial persists | | | | | | | 1 | 0.13% |
| 33 | whi trial persists in | | | | | | | 1 | 0.13% |
| 34 | the long run but | | | | | | | 1 | 0.13% |
| 35 | long run but estrogen | | | | | | | 1 | 0.13% |
| 36 | run but estrogen alone | | | | | | | 1 | 0.13% |
| 37 | but estrogen alone may | | | | | | | 1 | 0.13% |
| 38 | estrogen alone may protect | | | | | | | 1 | 0.13% |
| 39 | cancer comparable with the | | | | | | | 1 | 0.13% |
| 40 | with the 24 greater | | | | | | | 1 | 0.13% |